Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Researchers at Weill Cornell Medicine have made promising advances in understanding how to reduce anxiety through specific brain circuitry, potentially leading to more effective treatments without the ...